SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-21-004159
Filing Date
2021-11-10
Accepted
2021-11-10 17:10:07
Documents
68
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q fnch-20210930.htm   iXBRL 10-Q 3336239
2 EX-10.1 fnch-ex10_1.htm EX-10.1 112367
3 EX-10.2 fnch-ex10_2.htm EX-10.2 518853
4 EX-31.1 fnch-ex31_1.htm EX-31.1 19850
5 EX-31.2 fnch-ex31_2.htm EX-31.2 20138
6 EX-32.1 fnch-ex32_1.htm EX-32.1 20615
  Complete submission text file 0000950170-21-004159.txt   9547186

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT fnch-20210930.xsd EX-101.SCH 53947
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT fnch-20210930_pre.xml EX-101.PRE 322132
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT fnch-20210930_lab.xml EX-101.LAB 423736
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT fnch-20210930_def.xml EX-101.DEF 222562
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT fnch-20210930_cal.xml EX-101.CAL 43615
12 EXTRACTED XBRL INSTANCE DOCUMENT fnch-20210930_htm.xml XML 1213816
Mailing Address 200 INNER BELT ROAD SOMERVILLE MA 02143
Business Address 200 INNER BELT ROAD SOMERVILLE MA 02143 617-229-6499
Finch Therapeutics Group, Inc. (Filer) CIK: 0001733257 (see all company filings)

IRS No.: 823433558 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40227 | Film No.: 211397735
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences